Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | USP2 | O75604 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30869590 | 0.87 | PIM1 (0.45) | MAPK1TSHRKMT2AMEN1 | |
| SCHEMBL30869613 | 0.85 | MAPK1 (0.32) | MAPK1 | |
| SCHEMBL30869403 | 0.84 | EGFR (0.43) | TSHRSMN1; SMN2 | |
| SCHEMBL30869652 | 0.84 | EGFR (0.41) | TSHRSMN1; SMN2 | |
| SCHEMBL30869592 | 0.83 | PRMT5 (0.31) | MAPK1 | |
| SCHEMBL30869621 | 0.81 | TSHR (0.50) | TSHRSMN1; SMN2 | |
| SCHEMBL30869759 | 0.76 | HTT (0.35) | — | |
| SCHEMBL30869767 | 0.76 | TSHR (0.47) | TSHRKMT2ASMN1; SMN2GAAMEN1 | |
| SCHEMBL30869389 | 0.75 | AHR (0.34) | MAPK1TSHRKMT2AMEN1 | |
| SCHEMBL30869597 | 0.73 | PIM1 (0.50) | MAPK1TSHRKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4583868-A2 | DYNAMIN ACTIVATORS | Walden Biosciences, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054661-A2 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES (US) | 2024-03-14 | — | — | WO | disclosed |